In­smed plots up­com­ing med launch­es built on its first drug lessons and con­sumer play­book mar­ket­ing strate­gies

With its first drug launch in the books, In­smed is now fo­cus­ing on build­ing out a road map for up­com­ing prod­ucts – with an eye on con­sumer mar­ket­ing strate­gies.

For CEO Will Lewis, that means tap­ping con­sumer in­sights as ear­ly as pos­si­ble and de­vel­op­ing prod­ucts and pack­ag­ing that are in­tu­itive and easy to use. It al­so means trans­lat­ing those pa­tient ex­pe­ri­ences in­to cre­ative and atyp­i­cal bio­phar­ma mar­ket­ing, and in both cas­es, tak­ing a page from con­sumer mar­keters’ play­books.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER